387520007: Bendroflumethiazide (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Diuretic (substance)\Thiazide diuretic (substance)\Bendroflumethiazide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Thiazide\Benzothiadiazine (substance)\Bendroflumethiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendroflumethiazide (substance)	Is a	Thiazide diuretic (substance)	true	Inferred relationship	Some
Bendroflumethiazide (substance)	Is a	Benzothiadiazine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendroflumethiazide measurement	Component	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendrofluazide poisoning (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Accidental bendrofluazide poisoning (disorder)	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Intentional bendrofluazide poisoning (disorder)	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendrofluazide poisoning of undetermined intent	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendrofluazide adverse reaction (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Allergy to bendroflumethiazide	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendrofluazide overdose (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Accidental bendrofluazide overdose (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Intentional bendrofluazide overdose (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendrofluazide overdose of undetermined intent	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide 5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide + nadolol 5mg/40mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide + nadolol 5mg/80mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing bendroflumethiazide and nadolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Timolol maleate+bendroflumethiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing bendroflumethiazide and potassium (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Propranolol hydrochloride + bendrofluazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Bendroflumethiazide + nadolol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Accidental bendrofluazide poisoning (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Intentional bendrofluazide poisoning (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Product containing atenolol and bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing bendroflumethiazide and propranolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing bendroflumethiazide and timolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some
Allergy to bendroflumethiazide	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Administration of prophylactic bendroflumethiazide (procedure)	Direct substance	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Atenolol- and bendroflumethiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide- and timolol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing bendroflumethiazide and potassium chloride in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide- and propranolol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing bendroflumethiazide and potassium chloride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing only atenolol and bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing only bendroflumethiazide and nadolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide and potassium only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide and potassium chloride only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide and propranolol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing only bendroflumethiazide and timolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide and nadolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide and potassium chloride only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide and propranolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing only bendroflumethiazide and timolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Product containing only bendroflumethiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1
Administration of prophylactic bendroflumethiazide (procedure)	Direct substance	True	Bendroflumethiazide (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461698010	Bendroflumethiazide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481610010	Bendroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492142019	Bendrofluazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492143012	Benzydroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1847251000195116	bendroflumetiazide	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
793791000172114	bendrofluméthiazide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
402001000274114	Bendroflumethiazid	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module